← All organizations

E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

For profitWebsite ↗

Also known as: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 12, 2025

Timeline

2020s

Jan 1, 2020
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.— Founded

Drugs by trial phase (3 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

qy201

Phase 2 (1 own, 0 via acquisition)

qy101

Phase 1 (1 own, 0 via acquisition)

qy211

Recent trials (5)

NCT07180511Lead sponsorPhase 3Mar 12, 2025
NCT06170840Lead sponsorPhase 2May 17, 2023
NCT05843422Lead sponsorPhase 1Mar 1, 2023
NCT05525715Lead sponsorPhase 1/Phase 2Oct 31, 2022
NCT05429177Lead sponsorPhase 1Jun 30, 2022

Details

Founded: Hangzhou, CN Jan 1, 2020
Last known activity: Mar 12, 2025